CommercialCoverageMedium impact
State and School Employees' Health Insurance Plan - Monoclonal Antibody Therapies for Migraine Prevention
Blue Cross & Blue Shield of Mississippi·MS · Neurology, Family Medicine, Internal Medicine +1 more·Medical Policy
We identified it
Jun 20, 2026
Summary
The State and School Employees' Health Insurance Plan has classified Vyepti (eptinezumab-jjmr) injections for migraine prevention as not medically necessary due to availability of other formulary alternatives. Claims for this monoclonal antibody therapy and its administration will be denied.
Action Required
Immediately: Stop billing HCPCS code J3032 (injection, eptinezumab-jjmr, 1 mg) for State and School Employees' Health Insurance Plan members. Billing team must update system to flag this code as non-covered for this specific plan. Providers should use formulary alternatives for migraine prevention treatment. Claims submitted for J3032 will be denied as not medically necessary.